Submitted by Anonymous (not verified) on 16 October 2023 - 14:45
Human medicines European public assessment report (EPAR): Enerzair Breezhaler, indacaterol,glycopyrronium bromide,mometasone, Asthma, Date of authorisation: 03/07/2020, Revision: 6, Status: Authorised
Source: